ARCHIVES

Funding and Direction of IL-2/LAK Trials Questioned By DCT Board

This article is from The Cancer Letter archive.

Vol. 15 No. 09 | March 3, 1989

Download PDF Visit The Full Archive

Related Articles

Taxotere Encouraging, CPT-11, Other Agents Entering Trials; Chabner

July 10, 1992

FDA Approves Silicone Gel Breast Implants, Requires 10 Years Of Patient Follow-Up

November 24, 2006

Clearinghouse Funds Two Carcinogens And A Threat To Humans

March 17, 1978

Bypass Budget For FY Seeks $1.189 Billion, Would Fund 1,018 Competing Grants, Restore Cuts

May 20, 1983

Report Tells NCI to Increase Funding for SPOREs.

June 30, 2006

Change In Method Of Counting Cancer Incidence Results In More Attributed To Work Hazards

October 6, 1978